PATENT CLAIM ANALYSIS

Application Number: 15987539
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "489000"]

Abstract:
The invention in suitable embodiments is directed to purified clathrin protein therapeutics. In one aspect, one or more purified clathrin protein therapeutic, formed in whole or in part from isolated, synthetic and or recombinant amino acid residues comprising in whole or in part one or more clathrin heavy chain protein and isoforms thereof, forms one or more type of therapeutic agent for treating psychiatric disorders.

Claim (Index 1):
A pharmaceutical composition, comprising at least one of a nanoparticle arrangement (NA) comprised of a plurality of clathrin protein nanoparticles and each NA is not a clathrin protein cage arrangement, each clathrin protein nanoparticle comprising one or more of a full length SEQ ID NO:1 or a humanized variant thereof, and the NA can pass through the blood brain barrier of a subject, and the preceding NA further can treat at least one of a psychiatric disorder, or a condition associated with psychiatric, in the subject.

Metadata:
- Claim Count in Document: 97.0
- Percentile: 93.0
- Lexical Diversity: 1.61364
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11024424', '10661465', '10661466', '10660976', '14700763']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6554987775424211
- 35 USC 102 Novelty (BERT): 0.5120490342758593
- Combined Prediction Score: 0.6411538032157649
- Mean Citation Score: 193.364124
- Max Citation Score: 239.98927
- Similarity Product: 153.95829400953173

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test